Oligonucleotide therapies for nonalcoholic steatohepatitis

Nonalcoholic steatohepatitis (NASH) represents a severe disease subtype of nonalcoholic fatty liver disease (NAFLD) that is thought to be highly associated with systemic metabolic abnormalities. It is characterized by a series of substantial liver damage, including hepatocellular steatosis, inflamma...

Description complète

Détails bibliographiques

Auteurs principaux:	Sixu Li, Feng Xiong, Songbo Zhang, Jinghua Liu, Guangping Gao, Jun Xie, Yi Wang
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2024-06-01
Collection:	Molecular Therapy: Nucleic Acids
Sujets:	MT: Oligonucleotides: Therapies and Applications NASH NAFLD RNAi ASO siRNA
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2162253124000714
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!